ALLIANCEBERNSTEIN L.P. - BLUEBIRD BIO INC ownership

BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 164 filers reported holding BLUEBIRD BIO INC in Q3 2022. The put-call ratio across all filers is 0.70 and the average weighting 0.1%.

Quarter-by-quarter ownership
ALLIANCEBERNSTEIN L.P. ownership history of BLUEBIRD BIO INC
ValueSharesWeighting
Q3 2023$479,226
-7.6%
157,6400.0%0.00%
Q2 2023$518,636
+65.1%
157,640
+59.5%
0.00%
Q1 2023$314,216
-54.8%
98,810
-1.6%
0.00%
Q4 2022$694,664
-9.4%
100,385
-17.2%
0.00%
Q3 2022$767,000
+43.6%
121,185
-6.1%
0.00%
Q2 2022$534,000
+110.2%
129,010
+146.5%
0.00%
Q1 2022$254,000
-60.9%
52,330
-19.5%
0.00%
Q4 2021$650,000
-59.6%
65,030
-22.8%
0.00%
-100.0%
Q3 2021$1,609,000
-40.3%
84,2200.0%0.00%0.0%
Q2 2021$2,693,000
+301.3%
84,220
+278.4%
0.00%
Q1 2021$671,000
-52.2%
22,254
-31.4%
0.00%
-100.0%
Q4 2020$1,404,000
-68.7%
32,440
-61.0%
0.00%
-50.0%
Q3 2020$4,488,000
+130.5%
83,190
+160.9%
0.00%
+100.0%
Q2 2020$1,947,000
-43.2%
31,890
-57.3%
0.00%
-50.0%
Q1 2020$3,430,000
-27.7%
74,640
+38.1%
0.00%
-33.3%
Q4 2019$4,742,000
+98.3%
54,040
+107.5%
0.00%
+200.0%
Q3 2019$2,391,000
-56.8%
26,040
-40.2%
0.00%
-66.7%
Q2 2019$5,538,000
+3.2%
43,540
+27.6%
0.00%0.0%
Q1 2019$5,368,000
+76.2%
34,120
+11.1%
0.00%
+50.0%
Q4 2018$3,047,000
-93.3%
30,720
-90.2%
0.00%
-93.3%
Q3 2018$45,584,000
-9.7%
312,220
-2.9%
0.03%
-14.3%
Q2 2018$50,466,000
+4.0%
321,540
+13.1%
0.04%0.0%
Q1 2018$48,529,000
+195.0%
284,210
+207.7%
0.04%
+191.7%
Q4 2017$16,451,000
+50.8%
92,370
+16.3%
0.01%
+50.0%
Q3 2017$10,906,000
+23.5%
79,400
-5.6%
0.01%
+14.3%
Q2 2017$8,833,000
+13.2%
84,080
-2.1%
0.01%
+16.7%
Q1 2017$7,805,000
+121.1%
85,860
+50.1%
0.01%
+100.0%
Q4 2016$3,530,000
-7.4%
57,220
+1.8%
0.00%0.0%
Q3 2016$3,811,000
+54.7%
56,220
-1.2%
0.00%
+50.0%
Q2 2016$2,464,000
+196.9%
56,920
+191.4%
0.00%
+100.0%
Q1 2016$830,000
-33.1%
19,530
+1.1%
0.00%0.0%
Q4 2015$1,241,000
-25.7%
19,320
-1.0%
0.00%0.0%
Q3 2015$1,670,000
-47.8%
19,520
+2.7%
0.00%
-66.7%
Q2 2015$3,199,000
-32.1%
19,000
-51.3%
0.00%
-25.0%
Q1 2015$4,713,000
+46.0%
39,027
+10.9%
0.00%
+33.3%
Q4 2014$3,229,000
+202.9%
35,200
+18.5%
0.00%
+200.0%
Q3 2014$1,066,000
-4.7%
29,700
+2.4%
0.00%0.0%
Q2 2014$1,119,000
+111800.0%
29,000
+49900.0%
0.00%
Q1 2014$1,0000.0%580.0%0.00%
Q4 2013$1,000
-50.0%
580.0%0.00%
Q3 2013$2,000580.00%
Other shareholders
BLUEBIRD BIO INC shareholders Q3 2022
NameSharesValueWeighting ↓
Monashee Investment Management LLC 125,000$13,131,0005.55%
Cormorant Asset Management, LP 275,000$28,889,0004.79%
Eventide Asset Management 569,700$59,847,0003.73%
Crosspoint Capital Strategies, LLC 28,937$3,040,0002.66%
Casdin Capital, LLC 65,000$6,828,0002.53%
ARK Investment Management 119,683$12,573,0002.45%
RTW INVESTMENTS, LP 104,383$10,965,0002.31%
Taylor Wealth Management Partners 38,368$4,031,0001.82%
First Light Asset Management, LLC 33,780$3,549,0001.19%
Atika Capital Management LLC 25,000$2,627,0000.92%
View complete list of BLUEBIRD BIO INC shareholders